(Q40689373)

22 September 2017

title

Anti-myeloma activity of natural killer lymphocytes (English)

1 reference

22 September 2017

Christoph Frohn

1

1 reference

22 September 2017

Maike Höppner

2

1 reference

22 September 2017

Peter Schlenke

3

1 reference

22 September 2017

Holger Kirchner

4

1 reference

22 September 2017

Petra Koritke

5

1 reference

22 September 2017

Jürgen Luhm

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

British Journal of Haematology

22 September 2017

published in

1 reference

22 September 2017

volume

119

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

660-664

1 reference

Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03879.X

Feasibility of the adoptive transfusion of allogenic human leukocyte antigen-matched natural killer cells in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03879.X

Natural history of HLA expression during tumour development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03879.X

The enigma of the natural killer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03879.X

Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03879.X

Cell-mediated cytotoxicity. A highly sensitive and informative flow cytometric assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03879.X

Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03879.X

Independent contributions of HLA epitopes and killer inhibitory receptor expression to the functional alloreactive specificity of natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03879.X

Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03879.X

Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03879.X

10.1046/J.1365-2141.2002.03879.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference